Intellectual Property India Publishes Patent Application for '1,3,4-Oxadiazole Derivative Compounds As Histone Deacetylase 6 Inhibitor, And Uses Thereof' Filed by Chong Kun Dang Pharmaceutical Corp.

MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517029029 A) filed by Chong Kun Dang Pharmaceutical Corp., Seoul, Republic of Korea, on March 27, for '1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and uses thereof.'

Inventor(s) include Lee, Jae Kwang; Min, Jaeki; In, Jinkyung; Kim, Yi Hyun; Jeon, Bomi; and Kim, Hyunjin Michael.

The application for the patent was published on April 18, under issue no. 16/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a novel compound having histone deacetylase 6 (HDAC6) inhibitory activity, a method for preparing the same, and uses thereof. The novel compound according ...